Ticker Update: 3 HealthTech Stocks Trending (Open Now)

If you cannot see this email properly, please click [here]( [mmi-logo] Dear Reader, Below is a a list of 3 Healthtech Stocks that have appear to be trending by receiving buy ratings and showing positive investor sentiment, as well as news headlines. With that said, our editors are adding them to our watchlist to see if the momentum continues. --------------------------------------------------------------- [Copper More Critical than Lithium?]( [be7e813c-17c...](Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found. [See How You Can Benefit From New Copper Discoveries.](//trailer.web-view.net/Links/0X6ACC25A684EC5DDBF7A54CC451744DC0427041C8C20B1D3BF85349F9A43853F31C951B6C626A3931FA71B80142D217EFCBAE0B1D902A546397B78C110EC8F65BF598CD369566B7DD.htm [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Celldex, CLDX]( Summary: CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. Kristen Kluska analyst at Cantor Fitzgerald reiterates coverage on [Celldex (CLDX)](in the Health sector with a Buy rating and has set a price target of $ 59. [TipRanks.com]( reports that [Celldex](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $66.50. In addition, TradingView issued a Sell rating for [CLDX]( over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Bearish short-term outlook. [For the complete breakdown on CLDX, please click here >>]( --------------------------------------------------------------- [Talaris Therapeutics, TALS]( Summary: Talaris Therapeutics Inc. is a late-clinical stage cell therapy company. It involved in developing a method of allogeneic hematopoietic stem cell transplantation with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases and certain severe non-malignant blood, immune and metabolic disorders. Talaris Therapeutics Inc. is based in BOSTON. Vikram Purohit analyst at Morgan Stanley reiterates coverage on [Talaris Therapeutics (TALS)](in the Health sector with a Hold rating and has set a price target of $ 8. [TipRanks.com]( reports that [Talaris Therapeutics](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.67. In addition, TradingView issued a Sell rating for [TALS]( over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Bearish short-term outlook. [For the complete breakdown on TALS, please click here >>]( --------------------------------------------------------------- [Bear Market Legend Details 25 Stocks to Sell Now]( A legendary bear market investor believes the situation could get worse in 2022… [Learn how to get the names of the companies he says you MUST avoid.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Axsome Therapeutics, AXSM]( Summary: Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available. Charles Duncan analyst at Cantor Fitzgerald reiterates coverage on [Axsome Therapeutics (AXSM)](in the Health sector with a Buy rating and has set a price target of $ 64. [TipRanks.com]( reports that [Axsome Therapeutics](currently has 11 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $65.44. In addition, TradingView issued a Buy rating for [AXSM]( over the next month, Barchart.com has a Weak buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the complete breakdown on AXSM, please click here >>]( --------------------------------------------------------------- [Collect 5 dividend checks per week]( [e3708887-94b...](I just did the math in my own, real-money portfolio. I'll be collecting 70 dividend checks this quarter. That's nearly 5 per week on average. Automatically… no trading, no options, no work. You don't need a lot of money. You can be retired or near retirement... Either way, I'll show you my #1 plan to quickly collect dividends like clockwork from high-quality, cash-flowing business. [Click here to learn how to collect up to 5 dividends a week.](//trailer.web-view.net/Links/0X86AB6A82E7B37637E80BBE388AD67EFF3F5E762ACF0DF2A14CE306F48F3DD9CE361FD8F05D614994FA71B80142D217EFCBAE0B1D902A546397B78C110EC8F65BF598CD369566B7DD.htm [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- Remember, securities are volatile, so please do your own research. One resource you need to consider using [Tipranks.com]( where as a premium member you get access to all buy ratings, price targets and insider trading signals. [TipRanks.com]( tracks and measures the performance of over 50,000 financial experts. The TipRanks Star Ranking TM is calculated based on expert success rate, average return and statistical significance. [Get more from TipRanks.com here >>]( Thanks for reading! The Editor, [HealthTechMovers.com]( --------------------------------------------------------------- [Millionaire Trader Drops Bombshell... "The Only Trade You Will Ever Need"]( [a72edb60-343...](Silicon Valley trading millionaire says... “FORGET 99% of the Stock Market... Trade ONE Stock... ONCE Per Month – Over and Over Again!” He’s recommended REAL gains of 100%, 228%, and [373% in just 8-days – in any market condition.]( Leveraging a trading secret he’s used for years... helping over 171,000 regular people... It’s called: The [“One Stock Retirement”]( – a trading breakthrough to help anyone collect triple-digit profits regardless of trading experience, location, starting capital, or market condition. [Click here, it’s all revealed in this exclusive interview…]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- InsidersPress.com | United States | 8458030954 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software